CM
Caption Management Portfolio holdings
AUM
$1.09B
1-Year Return
4.13%
This Quarter Return
+0.25%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$569M
AUM Growth
-$541M
(-49%)
Cap. Flow
-$551M
Cap. Flow
% of AUM
-96.88%
Top 10 Holdings %
Top 10 Hldgs %
32.37%
Holding
1,023
New
229
Increased
81
Reduced
147
Closed
200
Top Buys
| 1 |
EQT Corp
EQT
|
+$21M |
| 2 |
Zoom
ZM
|
+$12.1M |
| 3 |
CANO
Cano Health, Inc.
CANO
|
+$7.15M |
| 4 |
Sabre
SABR
|
+$6.27M |
| 5 |
PING
Ping Identity Holding Corp.
PING
|
+$6.13M |
Top Sells
| 1 |
Diamondback Energy
FANG
|
+$57.8M |
| 2 |
Trip.com Group
TCOM
|
+$55.1M |
| 3 |
Devon Energy
DVN
|
+$41.2M |
| 4 |
Freeport-McMoran
FCX
|
+$34.3M |
| 5 |
X
US Steel
X
|
+$21.7M |
Sector Composition
| 1 | Energy | 25.74% |
| 2 | Healthcare | 19.23% |
| 3 | Technology | 11.5% |
| 4 | Materials | 11.15% |
| 5 | Consumer Discretionary | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
PBF Energy
PBF
$3.29B
| $338K | ﹤0.01% |
9,600
-19,775
| -67% | -$696K |
|
277
Affirm
AFRM
$28B
| $337K | ﹤0.01% |
+18,000
| New | +$337K |
|
278
Protagonist Therapeutics
PTGX
$3.5B
| $337K | ﹤0.01% |
40,000
+29,600
| +285% | +$249K |
|
279
Schrodinger
SDGR
$1.43B
| $337K | ﹤0.01% |
13,453
-96,000
| -88% | -$2.4M |
|
280
MBIA
MBI
$386M
| $334K | ﹤0.01% |
36,330
-3,670
| -9% | -$33.7K |
|
281
DoubleVerify
DV
$2.53B
| $327K | ﹤0.01% |
+12,000
| New | +$327K |
|
282
FTAI Aviation
FTAI
$17.1B
| $327K | ﹤0.01% |
+21,785
| New | +$327K |
|
283
Cabot Corp
CBT
$4.31B
| $320K | ﹤0.01% |
5,000
| – | – |
|
284
iShares US Real Estate ETF
IYR
$3.74B
| $320K | ﹤0.01% |
+3,936
| New | +$320K |
|
285
Kodiak Sciences
KOD
$517M
| $319K | ﹤0.01% |
+41,200
| New | +$319K |
|
286
Funko
FNKO
$184M
| $317K | ﹤0.01% |
+15,700
| New | +$317K |
|
287
International Paper
IP
$25B
| $317K | ﹤0.01% |
10,000
| – | – |
|
288
Dave & Buster's
PLAY
$805M
| $315K | ﹤0.01% |
10,132
+1,732
| +21% | +$53.8K |
|
289
Exelixis
EXEL
$10.1B
| $314K | ﹤0.01% |
+20,000
| New | +$314K |
|
|
ITCI
290
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $312K | ﹤0.01% |
+6,705
| New | +$312K |
|
|
CHNG
291
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $310K | ﹤0.01% |
11,300
-21,900
| -66% | -$601K |
|
292
Celldex Therapeutics
CLDX
$1.52B
| $307K | ﹤0.01% |
+10,944
| New | +$307K |
|
293
Golar LNG
GLNG
$4.52B
| $306K | ﹤0.01% |
+12,276
| New | +$306K |
|
294
S&P Global
SPGI
$167B
| $306K | ﹤0.01% |
1,000
-31,450
| -97% | -$9.62M |
|
295
Monster Beverage
MNST
$61.5B
| $305K | ﹤0.01% |
+7,000
| New | +$305K |
|
296
Liquidia Corp
LQDA
$2.41B
| $303K | ﹤0.01% |
+55,536
| New | +$303K |
|
297
Groupon
GRPN
$920M
| $301K | ﹤0.01% |
37,817
+10,000
| +36% | +$79.6K |
|
298
Inspire Medical Systems
INSP
$2.47B
| $301K | ﹤0.01% |
1,700
-13,300
| -89% | -$2.35M |
|
299
NeoGenomics
NEO
$1.02B
| $298K | ﹤0.01% |
+34,700
| New | +$298K |
|
|
CMRC
300
Commerce.com, Inc. Series 1 Common Stock
CMRC
$361M
| $296K | ﹤0.01% |
20,000
+10,000
| +100% | +$148K |
|